1) Recurrent Esophageal variceal bleeding
门静脉血管阻力
2) the parameter of portal
门静脉血管参数
3) portal vein blood
门静脉血
1.
Clinical significance of the expression of CK20 mRNA in portal vein blood of patients with colorectal cancer during operation;
大肠癌术中门静脉血CK20 mRNA检测临床意义的探讨
2.
Methods:CK20 mRNA was detected in Portal vein blood samples of patients with rectal cancer before and after operation from 50 patients by reverse transcription polymerase chain reaction (RT-PCR).
目的 :研究直肠癌门静脉血 CK2 0 m RNA表达及临床意义。
4) portal vein blocking
门静脉阻断
1.
Objective To investigate the effect of long-time portal vein blocking on liver and gut at normothermia temporarily and their correlations,determine whether portal vein blood can reflow into systemic circulation by portal-systemic collaterals.
目的观察常温下长时间门静脉阻断再通后对肝脏、肠道的影响及与阻断时间的关系,明确有无门体侧枝开放及与门静脉阻断耐受性的关系。
2.
Objective To investigate the effect on liver and gut after long-time portal vein blocking at normothermia temporarily and their correlations ,determine whether portal vein blood can reflow into systemic circulation by portal-systemic collaterals.
目的观察常温下长时间门静脉阻断再通后对肝脏、肠道结构功能的影响及其与阻断时间的关系,明确有无门体侧枝开放及其与门静脉阻断耐受性的关系。
5) portal vein obstruction
门静脉阻塞
1.
Objective To evaluate the efficacy of the rheolytic thrombectomy catheter(Hydrolyser)for treatment of portal vein obstruction.
目的 评价流变溶栓导管 (Hydrolyser)对门静脉阻塞再通治疗的临床疗效。
补充资料：垂体门静脉系统
垂体门静脉系统
是下丘脑和垂体前叶间的一个特殊的血液循环体系。垂体上动脉在正中隆起处首先形成丰富的毛细血管丛，是为门静脉前毛细血管丛，此丛汇集成若干条静脉于，即垂体门静脉。它们沿垂体柄下行进入垂体前叶，再次分支形成毛细血管丛，是为门静脉后毛细血管丛。这种特殊的血管构筑称为"垂体门静脉系统"。该系与腺垂体分泌的调节有密切关联。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条